OICR | GenomeWeb

OICR

In two studies, researchers sequenced nearly 500 tumors to uncover hallmarks of aggressive prostate cancer.

An analysis of copy number changes and genomic rearrangements in more than 100 tumors suggests chromothripsis may contribute to pancreatic cancer evolution.

The Ontario Institute for Cancer Research will work with prostate cancer data while Dana Farber Cancer Institute's pilot has yet to be decided.

The partners will work on pilot projects that use novel analytical approaches to explore oncology molecular and imaging data.

Researchers in Canada and the UK have used data from the Oxford Nanopore MinIon alone to assemble a bacterial genome into a single contig.

The International Cancer Genome Consortium has selected Annai Systems to host data from more than 10,000 human cancer genomes.

NEW YORK (GenomeWeb) – In Nature Genetics, researchers from the Memorial Sloan Kettering Cancer Center, the Ontario Institute for Cancer Research, the University of Toronto, and elsewhere described

NEW YORK (GenomeWeb) – The Ontario Institute for Cancer Research has joined the Open Cloud Consortium (OCC), a non-profit that provides cloud infrastructure to support science communities, and the partners plan to create a cancer genomics resource.

NEW YORK (GenomeWeb) – A research team led by scientists at the Ontario Institute for Cancer Research have received a C$5 million (US$4.7 million) grant from the Movember Foundation to develop diagnostic molecular markers that physicians could use to make treatment decisions for their prostate ca

NEW YORK (GenomeWeb) – Scientists in Canada and Israel will partner to investigate pancreatic cancer, identify drivers of disease metastasis, and discover biomarkers for use in identifying and treating the disease, the Ontario Institute for Cancer Research said today.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.